2 results
Approved WMOCompleted
Primary: Antiviral efficacy of dolutagravir in combination with Kivexa (abacavir en lamivudine) after 48 weeks of treatment in comparison with Atripla (tenofovir, emtricitabine and efavirenz). Secondary: Antiviral efficacy after 96 and 144 weeks,…
Approved WMOPending
The main objective of this project is to associate the gut microbial community with treatment efficacy (i.e., relieve in symptoms and side effects) in patients with suspected treatment-resistant depression. The secondary objective of this project is…